PMV PharmaceuticalsPMVP
13F holders, Q3 2024 (September 30)74holders −19
4new positions
23sold out
3famous investors
$1.49avg. 13F price*
At the end of Q3 2024, 74 institutions reported holding PMV Pharmaceuticals Inc. (PMVP) in their 13F filings, down 19 from Q2 2024. 4 opened new positions and 23 sold out. The largest holders were Orbimed Advisors LLC ($9.6M), ArrowMark Colorado Holdings LLC ($5.4M) and Sio Capital Management, LLC ($4.8M). 3 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- PMV Pharmaceuticals Inc.
- CUSIP
- 69353Y103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $216K |
| Exits | 23 | $3.2M |
All 13F filers, Q2 2024 → Q3 2024: 3,718,203 shares bought and 5,169,651 shares sold, net −1,451,448 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 74 holders
| Orbimed Advisors LLC | 0.18% | No change | 6,475,291 | $9.6M |
| ArrowMark Colorado Holdings LLC | 0.07% | Add +30.0% | 3,647,291 | $5.4M |
| Sio Capital Management, LLC | 2.15% | Add +18.7% | 3,214,239 | $4.8M |
| Euclidean Capital LLC | 0.43% | No change | 2,627,643 | $3.9M |
| Alkeon Capital Management LLC | 0.02% | Reduce -0.1% | 2,343,731 | $3.5M |
| Vanguard Group Inc. | 0.00% | Reduce -0.1% | 2,280,803 | $3.4M |
| Acadian Asset Management LLC | 0.01% | No change | 2,078,866 | $3.1M |
| PFM Health Sciences, LP | 0.18% | Add +57.7% | 2,011,040 | $3.0M |
| BML Capital Management, LLC | 1.48% | Add +29.0% | 1,688,772 | $2.5M |
| BlackRock, Inc. | 0.00% | — | 1,144,797 | $1.7M |
| Citadel Advisors | 0.00% | Reduce -38.5% | 1,055,696 | $1.6M |
| D. E. Shaw & Co. | 0.00% | Add +2.0% | 1,040,477 | $1.6M |
| Two Sigma Advisers, LP | 0.00% | Add +52.2% | 751,200 | $1.1M |
| Jacobs Levy Equity Management, Inc. | 0.00% | Reduce -9.4% | 705,593 | $1.1M |
| Personal Cfo Solutions, LLC | 0.11% | No change | 550,342 | $820K |
| Citigroup Inc. | 0.00% | Reduce -0.1% | 514,915 | $767K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -36.9% | 510,004 | $760K |
| Two Sigma Investments, LP | 0.00% | Add +24.4% | 483,055 | $720K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +0.4% | 441,024 | $657K |
| Acuitas Investments, LLC | 0.29% | Add +24.6% | 440,687 | $657K |
| Aldebaran Capital, LLC | 0.60% | Add +24.8% | 438,252 | $653K |
| Geode Capital Management, LLC | 0.00% | Add +1.2% | 432,762 | $645K |
| M&T Bank Corp | 0.00% | Add +54.6% | 399,548 | $596K |
| Millennium Management | 0.00% | Reduce -52.0% | 363,969 | $542K |
| Assenagon Asset Management S.A. | 0.00% | Add +36.1% | 353,837 | $527K |
| Baker Bros. Advisors LP | 0.01% | No change | 322,024 | $480K |
| RBF Capital, LLC | 0.02% | No change | 253,361 | $388K |
| Shay Capital LLC | 0.08% | Add +13.7% | 188,051 | $280K |
| UBS Group AG | 0.00% | Add +110.7% | 178,866 | $267K |
| Walleye Capital LLC | 0.00% | No change | 145,737 | $217K |
| State Street Corp. | 0.00% | No change | 145,078 | $216K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 139,900 | $208K |
| Evoke Wealth, LLC | 0.01% | Add +110.5% | 133,122 | $198K |
| Dimensional Fund Advisors LP | 0.00% | No change | 126,004 | $188K |
| Bank of America Corp. | 0.00% | Reduce -64.5% | 120,770 | $180K |
| ADAR1 Capital Management, LLC | 0.03% | Add +102.0% | 101,008 | $151K |
| Panagora Asset Management Inc. | 0.00% | New | 89,631 | $134K |
| Northern Trust Corp. | 0.00% | Reduce -73.1% | 87,150 | $130K |
| Jane Street Group, LLC | 0.00% | Reduce -54.8% | 74,089 | $110K |
| Gsa Capital Partners LLP | 0.01% | Reduce -5.7% | 73,352 | $109K |
| PNC Financial Services Group, Inc. | 0.00% | Add +60.1% | 69,229 | $103K |
| Schonfeld Strategic Advisors LLC | 0.00% | Reduce -48.3% | 66,900 | $100K |
| Marquette Asset Management, LLC | 0.02% | No change | 64,009 | $95K |
| Marshall Wace, LLP | 0.00% | Add +378.2% | 61,691 | $92K |
| Morgan Stanley | 0.00% | Reduce -50.2% | 59,421 | $89K |
| Susquehanna International Group, LLP | 0.00% | Reduce -49.0% | 44,160 | $66K |
| Squarepoint Ops LLC | 0.00% | Reduce -15.3% | 43,293 | $65K |
| Ameriprise Financial Inc. | 0.00% | Reduce -20.6% | 39,522 | $59K |
| HSBC Holdings PLC | 0.00% | Reduce -10.6% | 39,080 | $59K |
| Prelude Capital Management, LLC | 0.00% | Reduce -72.5% | 37,100 | $55K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 33,600 | $51K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -48.6% | 32,190 | $48K |
| Barclays PLC | 0.00% | Reduce -93.5% | 30,248 | $45K |
| Virtu Financial LLC | 0.00% | New | 28,146 | $42K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -63.4% | 26,257 | $39K |
| Amundi | 0.00% | New | 26,182 | $39K |
| HighTower Advisors, LLC | 0.00% | Reduce -0.6% | 24,880 | $37K |
| XTX Topco Ltd | 0.00% | Reduce -83.6% | 24,160 | $36K |
| Group One Trading LLC | 0.00% | Add +24.4% | 15,983 | $24K |
| Independent Advisor Alliance | 0.00% | Add +6.2% | 13,273 | $20K |
| Public Employees Retirement System of Ohio | 0.00% | Reduce -40.6% | 12,738 | $19K |
| HarbourVest Partners LLC | 0.01% | No change | 11,533 | $17K |
| Simplex Trading, LLC | 0.00% | Reduce -61.9% | 11,711 | $17K |
| Corient Private Wealth LP | 0.00% | No change | 10,000 | $15K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -87.6% | 8,648 | $13K |
| Federated Hermes, Inc. | 0.00% | Add +112.3% | 8,244 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -85.3% | 2,187 | $3K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 2,100 | $3K |
| Nordwand Advisors, LLC | 0.00% | No change | 2,000 | $3K |
| Osaic Holdings, Inc. | 0.00% | New | 1,320 | $2K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.5% | 1,032 | $2K |
| FMR LLC | 0.00% | Reduce -72.0% | 1,005 | $1K |
| Nisa Investment Advisors, LLC | 0.00% | Add +61.5% | 105 | $156 |
| Royal Bank of Canada | 0.00% | Reduce -98.0% | 48 | $0 |
"% of holder's portfolio" is PMVP's weight in each manager's 13F, not the share of PMV Pharmaceuticals Inc. the manager owns.